Abstract:The role of machine learning (a part of artificial intelligence—AI) in the diagnosis and treatment of various types of oncology is steadily increasing. It is expected that the use of AI in oncology will speed up both diagnostic and treatment planning processes. This review describes recent applications of machine learning in oncology, including medical image analysis, treatment planning, patient survival prognosis, and the synthesis of drugs at the point of care. The fast and reliable analysis of medical images is of great importance in the case of fast-flowing forms of cancer. The introduction of ML for the analysis of constantly growing volumes of big data makes it possible to improve the quality of prescribed treatment and patient care. Thus, ML is expected to become an essential technology for medical specialists. The ML model has already improved prognostic prediction for patients compared to traditional staging algorithms. The direct synthesis of the necessary medical substances (small molecule mixtures) at the point of care could also seriously benefit from the application of ML. We further review the main trends in the use of artificial intelligence-based technologies in modern oncology. This review demonstrates the future prospects of using ML tools to make progress in cancer research, as well as in other areas of medicine. Despite growing interest in the use of modern computer technologies in medical practice, a number of unresolved ethical and legal problems remain. In this review, we also discuss the most relevant issues among them.

What problem does this paper attempt to address?

The paper reviews the latest applications of machine learning (ML) in cancer research and treatment. The research covers the use of techniques such as deep learning, decision trees, and generative adversarial networks for cancer identification, optimization of treatment strategies, and prediction of patient survival rates. The authors discuss how ML improves the efficiency of medical image analysis, particularly in handling large and continuously growing medical data, to enhance diagnostic quality and treatment planning. In addition, the paper mentions the potential role of ML in personalized medicine, such as its application in point-of-care drug synthesis. While ML has improved prediction accuracy in cancer diagnostics, such as in radiogenomics, there are still challenges, such as data anonymization and ethical and legal issues. The authors cite multiple cases to illustrate the specific applications of ML in disease diagnostics, such as lung cancer and prostate cancer, including the improvement of diagnostic efficiency and prediction accuracy through feature extraction and machine learning algorithms. The paper also discusses the role of big data in radiation oncology and how to utilize distributed systems for data analysis while protecting patient privacy. Overall, this paper aims to address how to utilize machine learning techniques to improve cancer diagnosis, treatment prediction, and personalized medicine, while highlighting current challenges and future research directions.

Machine Learning Meets Cancer